Galectin Therapeutics, Inc. (GALT)
4.20
+0.06
(+1.45%)
USD |
NASDAQ |
Sep 09, 13:07
Galectin Therapeutics Price : 4.20 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 4.60 | 4.65 | 4.10 | 4.14 | 393417.0 |
| Sep 04, 2026 | 4.33 | 4.72 | 4.33 | 4.61 | 473554.0 |
| Sep 03, 2026 | 4.50 | 4.60 | 4.224 | 4.35 | 244150.0 |
| Sep 02, 2026 | 4.19 | 4.53 | 4.19 | 4.48 | 460696.0 |
| Sep 01, 2026 | 3.91 | 4.385 | 3.91 | 4.17 | 479583.0 |
| Aug 31, 2026 | 4.02 | 4.05 | 3.91 | 3.95 | 229714.0 |
| Aug 28, 2026 | 4.14 | 4.20 | 3.95 | 4.02 | 271187.0 |
| Aug 27, 2026 | 4.15 | 4.45 | 4.04 | 4.14 | 345234.0 |
| Aug 26, 2026 | 3.95 | 4.205 | 3.92 | 4.15 | 291107.0 |
| Aug 25, 2026 | 4.07 | 4.19 | 3.845 | 3.99 | 194722.0 |
| Aug 24, 2026 | 3.68 | 3.97 | 3.58 | 3.88 | 227963.0 |
| Aug 21, 2026 | 3.62 | 3.74 | 3.587 | 3.68 | 174933.0 |
| Aug 20, 2026 | 3.67 | 3.749 | 3.44 | 3.57 | 313109.0 |
| Aug 19, 2026 | 3.54 | 3.77 | 3.54 | 3.67 | 353794.0 |
| Aug 18, 2026 | 3.47 | 3.55 | 3.325 | 3.52 | 317939.0 |
| Aug 17, 2026 | 3.36 | 3.67 | 3.31 | 3.51 | 300046.0 |
| Aug 14, 2026 | 3.50 | 3.546 | 3.20 | 3.44 | 388207.0 |
| Aug 13, 2026 | 3.16 | 3.56 | 3.16 | 3.53 | 585304.0 |
| Aug 12, 2026 | 3.12 | 3.26 | 3.12 | 3.14 | 231492.0 |
| Aug 11, 2026 | 3.13 | 3.15 | 3.02 | 3.13 | 296151.0 |
| Aug 10, 2026 | 3.39 | 3.40 | 3.09 | 3.12 | 371113.0 |
| Aug 07, 2026 | 3.558 | 3.558 | 3.22 | 3.45 | 329875.0 |
| Aug 06, 2026 | 3.13 | 3.25 | 3.07 | 3.22 | 511185.0 |
| Aug 05, 2026 | 3.00 | 3.14 | 2.965 | 3.09 | 355020.0 |
| Aug 04, 2026 | 2.96 | 3.123 | 2.72 | 2.985 | 844237.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.80 |
| Alnylam Pharmaceuticals, Inc. | 255.30 |
| Anika Therapeutics, Inc. | 20.92 |
| Savara, Inc. | 5.395 |
| Vericel Corp. | 38.90 |
Price Related Metrics
| Earnings Yield | -10.23% |
| Market Cap | 278.51M |